HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisao Hayashi Selected Research

metal transporting protein 1 (ferroportin)

3/2021Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism.
10/2018A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign.
8/2018The interactions between iron and copper in genetic iron overload syndromes and primary copper toxicoses in Japan.
3/2017Iron overload patients with unknown etiology from national survey in Japan.
6/2015Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes.
6/2014A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.
9/2012Clinicopathological study of Japanese patients with genetic iron overload syndromes.
11/2010Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
1/2006Genetic background of primary iron overload syndromes in Japan.
9/2005A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisao Hayashi Research Topics

Disease

24Iron Overload
03/2021 - 09/2004
19Hemochromatosis (Bronze Diabetes)
03/2021 - 06/2003
15Hepatolenticular Degeneration (Wilson's Disease)
12/2019 - 11/2004
9Chronic Hepatitis C
11/2015 - 01/2002
7Anemia
08/2020 - 11/2008
5Hyperferritinemia
03/2021 - 09/2005
5Liver Diseases (Liver Disease)
03/2017 - 09/2004
5Chronic Idiopathic Jaundice (Dubin Johnson Syndrome)
10/2007 - 01/2003
4Fibrosis (Cirrhosis)
06/2014 - 11/2004
3Liver Failure
08/2018 - 01/2010
3Hyperbilirubinemia
10/2004 - 01/2003
2type 2 Hemochromatosis
01/2020 - 03/2012
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 01/2002
2Iron-Deficiency Anemia (Anemia, Iron Deficiency)
11/2015 - 02/2012
2Hepatitis
01/2010 - 08/2006
2Chronic Hepatitis (Chronic Active Hepatitis)
03/2009 - 11/2004
2Inflammation (Inflammations)
11/2008 - 01/2002
2Diabetes Mellitus
03/2005 - 06/2003
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Fatigue
01/2020
1Atrophy
10/2018
1Inborn Genetic Diseases (Disease, Hereditary)
08/2018
1Nervous System Diseases (Neurological Disorders)
01/2017
1Hepatomegaly
08/2013
1Iron Deficiencies
02/2012
1Thalassemia
01/2012
1Non-alcoholic Fatty Liver Disease
01/2012
1Brain Diseases (Brain Disorder)
01/2010
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2010
1Fatty Liver
06/2009
1Infections
11/2008
1Disease Progression
11/2008
1Hyperglycemia
05/2008
1Neoplasms (Cancer)
05/2008
1Massive Hepatic Necrosis
08/2006
1Jaundice (Icterus)
09/2004

Drug/Important Bio-Agent (IBA)

29IronIBA
03/2021 - 01/2002
16CopperIBA
12/2019 - 11/2004
10metal transporting protein 1 (ferroportin)IBA
03/2021 - 09/2005
10Familial apoceruloplasmin deficiencyIBA
08/2018 - 11/2004
7HepcidinsIBA
08/2018 - 11/2008
6Ferritins (Ferritin)IBA
12/2017 - 01/2010
5HemosiderinIBA
12/2017 - 02/2012
4Ceruloplasmin (Ferroxidase)IBA
08/2018 - 11/2006
4Transferrin Receptors (Transferrin Receptor)IBA
03/2017 - 06/2003
4ATP-Binding Cassette Sub-Family B Member 4IBA
04/2005 - 01/2003
3Transaminases (Aminotransferases)IBA
01/2020 - 01/2002
3Alanine Transaminase (SGPT)IBA
12/2019 - 06/2004
3Idiopathic Copper ToxicosisIBA
09/2013 - 09/2011
2Transferrin (beta 2 Transferrin)IBA
03/2021 - 09/2005
2EnzymesIBA
02/2014 - 01/2010
1copper oxidaseIBA
01/2017
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2015
1DeferasiroxFDA Link
11/2011
1Biomarkers (Surrogate Marker)IBA
11/2010
1Coloring Agents (Dyes)IBA
06/2009
1Fixatives (Pickling Agents)IBA
06/2009
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
03/2009
1Ribavirin (Virazole)FDA LinkGeneric
11/2008
1Hormones (Hormone)IBA
11/2008
1Messenger RNA (mRNA)IBA
11/2008
1Phorbol EstersIBA
05/2008
1Protein Kinase CIBA
05/2008
1Transcription Factors (Transcription Factor)IBA
05/2008
1NF-kappa B (NF-kB)IBA
05/2008
1LipofuscinIBA
11/2006
1Malondialdehyde (Propanedial)IBA
08/2006
1Heme (Haem)IBA
08/2006
1Trientine (Trien)FDA Link
10/2005
1Glucose (Dextrose)FDA LinkGeneric
03/2005
1Copper-Transporting ATPasesIBA
11/2004
1BilirubinIBA
09/2004
1InterferonsIBA
09/2004

Therapy/Procedure

8Therapeutics
05/2011 - 06/2004
3Chelation Therapy (Therapy, Chelation)
03/2017 - 11/2004
2Aftercare (After-Treatment)
02/2012 - 09/2006
1Slit Lamp
06/2012
1Drug Therapy (Chemotherapy)
01/2010
1Lasers (Laser)
11/2008